Literature DB >> 2991558

Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.

L R Stanberry, S Kit, M G Myers.   

Abstract

In guinea pigs, thymidine kinase-producing strains of herpes simplex virus type 2 replicated to high titer in the vagina and spinal cord, and animals developed severe clinical disease. Infection with thymidine kinase-deficient virus resulted in similar vaginal virus titers; however, animals exhibited little or no clinical illness and only low titers of virus were detected in spinal cord homogenate cultures. Neural and extraneural latent infection as well as recurrent infection were noted in animals inoculated with either thymidine kinase-producing or -deficient viruses. These data suggest that neural pathways are important in the pathogenesis of genital herpes and that virus-coded thymidine kinase may influence virulence but is not required for latency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991558      PMCID: PMC254936     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection.

Authors:  M Scriba
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Mitochondrial and herpesvirus-specific deoxypyrimidine kinases.

Authors:  W C Leung; D R Dubbs; D Trkula; S Kit
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

3.  Genital herpesvirus hominis infection in mice. I. Development of an experimental model.

Authors:  J C Overall; E R Kern; R L Schlitzer; S B Friedman; L A Glasgow
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

4.  Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding.

Authors:  A B Nesburn; M T Green; M Radnoti; B Walker
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

5.  Reactivation of latent Herpes simplex virus after pneumococcal pneumonia in mice.

Authors:  J G Stevens; M L Cook; M C Jordan
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

6.  Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.

Authors:  M A Walz; R W Price; A L Notkins
Journal:  Science       Date:  1974-06-14       Impact factor: 47.728

7.  Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

Authors:  A T Jamieson; G A Gentry; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

8.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

9.  Regulation of herpesvirus thymidine kinase activity in LM(TK) cells transformed by ultraviolet light-irradiated herpes simplex virus.

Authors:  S Kit; D R Dubbs
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

10.  Varicella-zoster virus infection of strain 2 guinea pigs.

Authors:  M G Myers; L R Stanberry; B J Edmond
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

View more
  17 in total

Review 1.  Control of STDs--the role of prophylactic vaccines against herpes simplex virus.

Authors:  L R Stanberry
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

2.  Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.

Authors:  S Kit; M Sheppard; H Ichimura; S Nusinoff-Lehrman; M N Ellis; J A Fyfe; H Otsuka
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  Chemotherapy of herpesvirus infections: present successes and future hopes.

Authors:  S Crowe; J Mills
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

4.  Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation.

Authors:  R B Tenser; W A Edris
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

5.  The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.

Authors:  Joshua O Marshak; Lichun Dong; David M Koelle
Journal:  Methods Mol Biol       Date:  2014

6.  Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia.

Authors:  W J Mitchell; S L Deshmane; A Dolan; D J McGeoch; N W Fraser
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.

Authors:  G N Milligan
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Nucleotide and amino acid sequence analysis of the thymidine kinase gene of a bovine encephalitis herpesvirus.

Authors:  G A Smith; P L Young; J S Mattick
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes.

Authors:  N Bourne; F J Bravo; W T Ashton; L C Meurer; R L Tolman; J D Karkas; L R Stanberry
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection.

Authors:  William J Muller; Lichun Dong; Adrian Vilalta; Benjamin Byrd; Kai M Wilhelm; Christopher L McClurkan; Michal Margalith; Chao Liu; David Kaslow; John Sidney; Alessandro Sette; David M Koelle
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.